Uni-Bio Science Group Limited — Share Issue/Capital Change 2017

Apr 3, 2017

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [25 x 25] intentionally omitted <==

==> picture [31 x 37] intentionally omitted <==

==> picture [24 x 29] intentionally omitted <==

==> picture [117 x 50] intentionally omitted <==

UNI-BIO SCIENCE GROUP LIMITED 聯康生物科技集團有限公司*

(Incorporated in the Cayman Islands with limited liability) (Stock code: 0690)

GRANT OF SHARE OPTIONS

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”).

The board of directors of Uni-Bio Science Group Limited (the “ Company ”) hereby announces that on 3 April 2017, share options (the “ Options ”) in respect of 36,960,000 ordinary shares of the Company (the “ Shares ”) were granted to eligible grantees under the share option scheme adopted by the Company on 28 September 2016. The followings are the details of the Options granted:

Date of grant : 3 April 2017 Number of Options granted : 36,960,000 Exercise price of Options granted : HK$0.1500 per Share Closing price of the Shares on the : HK$0.1480 per Share date of grant The average closing price of : HK$0.1488 per Share the Shares for the five business days immediately preceding the date of grant Validity period of the Options : From 3 April 2017 to 2 April 2027 Vesting period of the Options : (i) 16,600,000 Options are vested immediately on 3 April 2017; (ii) 10,690,000 Options will be vested on 3 April 2018; (iii) 9,670,000 Options will be vested on 3 April 2019.

• For identification purpose only

1

None of the grantees is a director, chief executive or substantial shareholder, or their respective associates (as defined in the Listing Rules).

By Order of the Board of Uni-Bio Science Group Limited Kingsley Leung Chairman

Hong Kong, 3 April 2017

As at the date of this announcement, the Board comprises two executive Directors, namely, Mr. Kingsley Leung (Chairman) and Mr. Chen Dawei (Vice-Chairman); and three independent non-executive Directors, namely, Dr. Carl Aslan Jason Morton Firth, Mr. Zhao Zhi Gang and Mr. Chow Kai Ming.

2